Nicotine Mini Lozenge
FDA Label NDC 72888-187

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Advagen Pharma Limited for the product Nicotine Mini (NDC 72888-187). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Container Label

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-53)

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-53)

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-53 - 27s Carton Label

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-53)

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-53)

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-54 - 81s Carton Label

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-54)

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-54)

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-55 - 108s Carton Label

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-55)

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-55)

Nicotine Polacrilex Lozenge, 2 mg - NDC 72888-186-56 - 135s Carton Label

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-56)

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-56)

* Please review the disclaimer below.